Literature DB >> 9595715

[Maximal functional capacity and diastolic function in patients with cardiomyopathy due to Chagas' disease without congestive heart failure].

C Mady1, B M Ianni, E Arteaga, V M Salemi, P R Silva, R H Cardoso, D Ballas.   

Abstract

PURPOSE: To identify early cardiac dysfunctions in asymptomatic patients with Chagas' cardiomyopathy.
METHODS: We studied 38 male individuals: control group consisting of 20 sedentary normal individuals and Chagas' group, of 18 asymptomatic patients with Chagas' disease, with suggestive electrocardiographic alterations and normal fractional shortening (FS) on echocardiogram. Both groups were submitted to evaluation of the maximal functional capacity, with measurements of maximal O2 consumption (VO2max), O2-pulse rate (PO2max), maximal ventilation (VEmax), maximal heart rate (HRmax), and anaerobic threshold of the VO2max (VO2-AT). Left ventricular diastolic function was evaluated by conventional echocardiography (E wave, A wave and E/A ratio).
RESULTS: No significant differences occurred between the two groups with regard to FS (p = 0.212) and age means (p = 0.060). The 2 groups were significantly different (p < 0.001) regarding the parameters VO2max, PO2max, VEmax, HRmax and VO2-AT, E wave and E/A ratio. There was no difference (p = 0.520) in A wave.
CONCLUSION: Impaired ventricular function may account for the above mentioned differences, a consequence of both systolic and diastolic dysfunctions.

Entities:  

Mesh:

Year:  1997        PMID: 9595715     DOI: 10.1590/s0066-782x1997001000003

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  1 in total

1.  Left Atrial Function in Patients with Chronic Chagasic Cardiomyopathy.

Authors:  Claudia da Silva Fragata; Afonso Y Matsumoto; Felix J A Ramires; Fabio Fernandes; Paula de Cássia Buck; Vera Maria C Salemi; Luciano Nastari; Charles Mady; Barbara Maria Ianni
Journal:  Arq Bras Cardiol       Date:  2015-05-08       Impact factor: 2.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.